Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy study
Open Access
- 10 November 2024
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 78, 102922
Abstract
No abstract availableKeywords
Funding Information
- Kom op tegen Kanker (ZKD6005, ZKE0164)
- Foundation Against Cancer (C/2014/185)
- Dutch Cancer Society (13192)
- Fonds Wetenschappelijk Onderzoek (1127523N)
- Charles University (207035)
This publication has 45 references indexed in Scilit:
- Congenital malformations: Prevalence and characteristics of newborns admitted into Federal Medical Center, AsabaHealth Science Reports, 2022
- Incidence of childhood hearing loss after in utero exposure to platinum agentsPrenatal Diagnosis, 2021
- Association of Chemotherapy Timing in Pregnancy With Congenital MalformationJAMA Network Open, 2021
- Association of Very Preterm Birth or Very Low Birth Weight With Intelligence in AdulthoodJAMA Pediatrics, 2021
- Pregnancy and Cancer: the INCIP ProjectCurrent Oncology Reports, 2020
- A Japanese survey of malignant disease in pregnancyInternational Journal of Clinical Oncology, 2018
- Prevalencia de trastornos del neurodesarrollo, comportamiento y aprendizaje en Atención PrimariaAnales de Pediatría, 2018
- Utilization of an ex vivo human placental perfusion model to predict potential fetal exposure to carboplatin during pregnancyAmerican Journal of Obstetrics and Gynecology, 2014
- Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancerMedical Oncology, 2013
- Comparative transplacental transfer of taxanes using the human perfused cotyledon placental modelAmerican Journal of Obstetrics and Gynecology, 2012